Search Results - "Zerbit, Jeremie"

Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia by Zerbit, Jérémie, Tamburini, Jerome, Goldwirt, Lauriane, Decroocq, Justine, Cayuela, Jean Michel, Chapuis, Nicolas, Contejean, Adrien, Batista, Rui, Bouscary, Didier, Willems, Lise

Get full text

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study by Zerbit, Jeremie, Chevret, Sylvie, Bernard, Sophie, Kroemer, Marie, Ablard, Charlotte, Harel, Stephanie, Brice, Pauline, Madelaine, Isabelle, Thieblemont, Catherine

“…Ibrutinib treatment has been shown to increase survival in patients with B cell malignancies. Real-life data suggest a large part of discontinuations are due…”
Get full text

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era by Zerbit, Jeremie, Detroit, Marion, Meyer, Antoine, Decroocq, Justine, Deau-Fischer, Benedicte, Deschamps, Paul, Birsen, Rudy, Mondesir, Johanna, Franchi, Patricia, Miekoutima, Elsa, Guerin, Corinne, Batista, Rui, Bouscary, Didier, Willems, Lise, Vignon, Marguerite

“…Patients with hematological malignancies are at greater risk of severe COVID-19 and have been prioritized for COVID-19 vaccination. A significant proportion of…”
Get full text

Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia by Puisset, Florent, Raffoux, Emmanuel, Ades, Lionel, Huynh, Tony, Itzykson, Raphaël, Bouscary, Didier, Aguinana, Loréa, Rabian, Florence, Sebert, Marie, Vekhoff, Anne, Brissot, Eolia, Mohty, Mohamad, Bonnin, Agnes, Genthon, Alexis, Zerbit, Jeremie, Willems, Lise, Decrocq, Justine, Contejean, Adrien, Lengline, Etienne, Mourah, Samia, Goldwirt, Lauriane

“…Not available.Not available…”
Get full text

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma by Henriquez, Soledad, Zerbit, Jérémie, Bruel, Timothée, Ouedrani, Amani, Planas, Delphine, Deschamps, Paul, Staropoli, Isabelle, Hadjadj, Jérôme, Varet, Bruno, Ermak, Natalia, Bouscary, Didier, Willems, Lise, Fouquet, Guillemette, Decroocq, Justine, Franchi, Patricia, Deau-Fischer, Benedicte, Terrier, Benjamin, Tamburini, Jérôme, Chatenoud, Lucienne, Schwartz, Olivier, Vignon, Marguerite

Get full text

Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer by Groussin, Lionel, Theodon, Hélène, Bessiene, Laura, Bricaire, Leopoldine, Bonnet-Serrano, Fidéline, Cochand-Priollet, Béatrix, Leroy, Karen, Garinet, Simon, Pasmant, Eric, Zerbit, Jérémie, Seban, Romain, Goldwasser, François, Clerc, Jérôme, Cottereau, Anne Segolene, Huillard, Olivier

“…Metastatic thyroid cancers may dedifferentiate and become radioactive-iodine (RAI) resistant. A redifferentiating effect can be observed with inhibitors of the…”
Get more information

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines) by Slimano, Florian, Baudouin, Amandine, Zerbit, Jérémie, Toulemonde-Deldicque, Anne, Thomas-Schoemann, Audrey, Chevrier, Régine, Daouphars, Mikaël, Madelaine, Isabelle, Pourroy, Bertrand, Tournamille, Jean-François, Astier, Alain, Ranchon, Florence, Cazin, Jean-Louis, Bardin, Christophe, Rioufol, Catherine

“…•The COVID-19 pandemic causes unprecedented impact on cancer patients.•Cancer patients are greater susceptible to COVID-19 infection and intense symptoms.•A…”
Get full text

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM) by Detroit, Marion, Collier, Mathis, Beeker, Nathanaël, Willems, Lise, Decroocq, Justine, Deau-Fischer, Bénédicte, Vignon, Marguerite, Birsen, Rudy, Moufle, Frederique, Leclaire, Clément, Balladur, Elisabeth, Deschamps, Paul, Chauchet, Adrien, Batista, Rui, Limat, Samuel, Treluyer, Jean-Marc, Ricard, Laure, Stocker, Nicolas, Hermine, Olivier, Choquet, Sylvain, Morel, Véronique, Metz, Carole, Bouscary, Didier, Kroemer, Marie, Zerbit, Jérémie

“…Immunotherapy (IT) is a major therapeutic strategy for lymphoma, significantly improving patient prognosis. IT remains ineffective for a significant number of…”
Get full text

Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study by Pinson, Pierre, Boussaid, Ismael, Decroocq, Justine, Chouchana, Laurent, Birsen, Gary, Barrois, Mathilde, Tsatsaris, Vassilis, Godeberge, Charlotte, Zerbit, Jeremie, Burroni, Barbara, Pene, Frederic, Huynh, Laurence, Charlier, Caroline, Tamburini, Jerome, Beeker, Nathanael, Collier, Mathis, Bouscary, Didier, Treluyer, Jean Marc, Birsen, Rudy

“…Pregnancy-associated haematological malignancy is a rare event; therefore, data available to guide the treatment are scarce. We aimed to evaluate the…”
Get full text

Access and use of quinacrine (mepacrine) in the treatment of resistant giardiasis by Delaye, Clemence, Suarez, Felipe, Aguilar, Claire, Guerin, Corinne, Batista, Rui, Chasport, Celine, Paugam, Andre, Zerbit, Jeremie

Get full text

Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis by Zerbit, Jeremie, Kroemer, Marie, Fuchs, Basile, Detroit, Marion, Decroocq, Justine, Vignon, Marguerite, Willems, Lise, Deau‐Fischer, Bénédicte, Franchi, Patricia, Deschamps, Paul, Contejean, Adrien, Grignano, Eric, Fouquet, Guillemette, Birsen, Rudy, Mondesir, Johanna, Rocquet, Mathieu, Huon, Jean‐François, Batista, Rui, Marty‐Reboul, Jeanne, Bouscary, Didier

“…Objective The clinical benefit of pharmaceutical cares in improving the quality‐of‐care outcomes is well demonstrated. Clinical pharmacy services are not…”
Get full text

Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients by Chouchana, Laurent, Boujaafar, Sana, Gana, Ines, Preta, Laure-Hélène, Regard, Lucile, Legendre, Paul, Azoulay, Celia, Canouï, Etienne, Zerbit, Jeremie, Carlier, Nicolas, Terrier, Benjamin, Kernéis, Solen, Batista, Rui, Treluyer, Jean-Marc, Zheng, Yi, Benaboud, Sihem

“…Although the efficacy of lopinavir/ritonavir has not been proven, it has been proposed as an off-label treatment for COVID-19. Previously, it has been reported…”
Get full text

Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19) by Zerbit, Jeremie, Detroit, Marion, Chevret, Sylvie, Pene, Frederic, Luyt, Charles-Edouard, Ghosn, Jade, Eyvrard, Frederic, Martin-Blondel, Guillaume, Sarton, Benjamine, Clere-Jehl, Raphael, Moine, Pierre, Cransac, Amelie, Andreu, Pascal, Labruyère, Marie, Albertini, Laetitia, Huon, Jean-François, Roge, Pauline, Bernard, Lise, Farines-Raffoul, Magali, Villiet, Maxime, Venet, Arnaud, Dumont, Louis Marie, Kaiser, Jean-Daniel, Chapuis, Claire, Goehringer, François, Barbier, François, Desjardins, Stephane, Benzidi, Younes, Abbas, Nora, Guerin, Corinne, Batista, Rui, Llitjos, Jean-François, Kroemer, Marie

“…Background. Given the rapidly evolving pandemic of COVID-19 in 2020, authorities focused on the repurposing of available drugs to develop timely and…”
Get full text

Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France by Ysebaert, Loïc, Ederhy, Stéphane, Leblond, Véronique, Malartre, Stéphanie, Portalier, Anaïs, Sibaud, Vincent, Tomowiak, Cécile, Zerbit, Jérémie

“…•This study aimed to establish consensus-based guidance for managing acalabrutinib-associated AEs in patients with CLL.•Hospital pharmacists should analyze…”
Get full text

Letter to the Editor: Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer by Groussin, Lionel, Bessiene, Laura, Arrondeau, Jennifer, Garinet, Simon, Cochand-Priollet, Béatrix, Lupo, Audrey, Zerbit, Jérémie, Clerc, Jérôme, Huillard, Olivier

Get more information

RCHOP Plus High-Dose Methotrexate As First-Line Therapy in Large B-Cell Lymphoma with Testis Involvement by Liévin, Raphaël, Burroni, Barbara, Palmic, Patricia, Balducci, Estelle, Decroocq, Justine, Deau Fischer, Benedicte, Franchi, Patricia, Vignon, Marguerite, Zerbit, Jérémie, Cottereau, Anne Ségolène, Kaltenbach, Sophie, Lhermitte, Ludovic, Bouscary, Didier, Willems, Lise

“…Primary testicular lymphoma (PTL) and diffuse large B-cell lymphoma with secondary testicular involvement (DLBCL-T) are rare subtypes of lymphomas associated…”
Get full text